Article
Risk of Inflammatory Bowel Disease in Psoriasis Patients Treated with Anti-Interleukin-17 Agents: A Bayesian Metaanalysis
2019-11-19
Abstract excerpt
<h4>Background</h4> Use of interleukin-17 inhibitors (IL-17i) in psoriasis has been associated with an increased risk of inflammatory bowel disease (IBD). However, the clinical significance of this association is not understood. <h4>Objectives</h4> To quantify the absolute risk of IBD in patients with psoriasis treated with IL-17i, stratified by known IBD risk factors. <h4>Methods</h4> Literature searches were per...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- df666716-d178-522a-9171-dfdef1b6efd1
- DOI
- 10.1101/19012179
